Evidence map›Paper›PMID 25506364›Full record

ArticleInternational journal of rheumatology2014

Effects of glossopharyngeal insufflation in ankylosing spondylitis: a pilot study.

Nina Brodin, Peter Lindholm, Claudia Lennartsson, Malin Nygren-Bonnier

Open access · hybridAbstract read
In one paragraph

Article in International journal of rheumatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 93% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nina BrodinDepartment of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, B3, Huddinge, 14183 Stockholm, Sweden ; Department of Orthopaedics, Division of Physiotherapy, Danderyd Hospital, 182 88 Stockholm, Sweden.
Peter LindholmDepartment of Radiology, Karolinska University Hospital, 171 76 Stockholm, Sweden ; Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Claudia LennartssonDepartment of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, B3, Huddinge, 14183 Stockholm, Sweden ; Department of Physical Therapy, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Malin Nygren-BonnierDepartment of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, B3, Huddinge, 14183 Stockholm, Sweden ; Department of Physical Therapy, Karolinska University Hospital, 141 86 Stockholm, Sweden.
Karolinska Institutet · SEDanderyds sjukhus · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Ankylosing Spondylitis (AS), thoracic range of motion is often greatly limited. The objective of the study was to describe the effects of 12 weeks of Glossopharyngeal Insufflation (GI) training in patients with AS. Dynamic spirometry included vital capacity, forced expiratory volume, and peak expiratory flow. Thoracic and lumbar range of motion was assessed by tragus-to-wall distance, modified Schober test, and tape measure. Disease activity, activity limitation, and health perception were assessed using the BAS-Indices, and tension in the thoracic region during GI was assessed using the Borg CR-10 scale. Adherence to training was recorded in an activity log, along with any remarks on the training. Ten patients were recruited and six male patients fulfilled the study protocol. Three patients were able to learn GI by exceeding their maximal vital capacity with 5% using GI. A significant increase in thoracic range of motion both on costae IV (P = 0.04) and at the level of the xiphoid process (P = 0.04) was seen. Thus, patients with AS can practice GI, it is safe if maximal exertion is avoided, and patients with some mobility in the chest can increase their lung function substantially by performing GI during 12 weeks.

Identifiers

PMID25506364
PMCPMC4258913
OpenAlexW1989024216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.